| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.31 | 0.01 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.074 | 0.01 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |